Consun Pharmaceutical continues share buyback program into November

Consun Pharmaceutical Group Limited (HKEX:1681) disclosed its latest share repurchase activities in a Next Day Disclosure Return submitted on November 3, 2025. On this date, the company repurchased 201,000 ordinary shares on the Exchange. The repurchase price per share ranged from HK$15.03 to HK$15.08, with an aggregate price paid of HK$3,029,760. These repurchased shares are currently held for cancellation.

The report details a series of repurchases from October 14, 2025, to November 3, 2025. As of the closing balance date, the total number of issued shares (excluding treasury shares) remained at 847,973,407.

The company's board of directors authorized the repurchase mandate on May 22, 2025, with a total of 85,126,334 shares authorized for repurchase. To date, 8,396,000 shares have been repurchased on the Exchange or another stock exchange, representing 9.863% of the issued shares (excluding treasury shares) as at the date of the resolution. A moratorium period for new share issues or sales of treasury shares after these repurchases extends up to December 3, 2025.